Document is current

Any future updates will be listed below

Continuation of Dual-Antiplatelet Therapy Following Percutaneous Revascularization with a Drug-Eluting Stent: What Duration Is Optimal?

Crossref DOI link: https://doi.org/10.1007/s11883-015-0543-4

Published Online: 2015-09-23

Published Print: 2015-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark